Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Ad26.COV2.S Emergency use authorization Experimental Vaccine Jun/22/2022 10 1
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Itolizumab Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/29/2021 4 0
INO-4800 Potential treatment - clinical evidence Experimental Vaccine Dec/23/2020 4 0
Candidate vaccine (Wuhan Institute of Biological Products and Wuhan Institute of Virology) Potential treatment - pre-clinical evidence Experimental Vaccine Nov/26/2020 3 0
Ad5-nCoV Potential treatment - clinical evidence Experimental Vaccine Aug/14/2020 4 0
hAd5 Potential treatment - pre-clinical evidence Experimental Vaccine Jul/30/2020 1 0